Anti-inflammatory therapies were associated with reduced risk of myocardial infarction in patients with established cardiovascular disease or high cardiovascular risks: A systematic review and meta-analysis of randomized controlled trials

被引:17
作者
Li, Zonglin [1 ]
Lin, Chu [1 ]
Cai, Xiaoling [1 ,2 ]
Hu, Suiyuan [1 ]
Lv, Fang [1 ]
Yang, Wenjia [1 ]
Zhu, Xingyun [1 ]
Ji, Linong [1 ,2 ]
机构
[1] Peking Univ Peoples Hosp, Dept Endocrinol & Metab, Beijing, Peoples R China
[2] Peking Univ Peoples Hosp, Dept Endocrinol & Metab, 11 Xizhimen South St, Beijing 100044, Peoples R China
基金
北京市自然科学基金; 中国国家自然科学基金;
关键词
Anti-inflammatory; Inflammation; Myocardial infarction; Cardiovascular disease; ACUTE CORONARY SYNDROME; NLRP3; INFLAMMASOME; P-SELECTIN; PART; ATHEROSCLEROSIS; HEART; INTERLEUKIN-1; IL-1; RECEPTOR; EVENTS;
D O I
10.1016/j.atherosclerosis.2023.06.972
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: We aimed to evaluate the association between anti-inflammatory therapies and the inci-dence of cardiovascular events in patients with established cardiovascular disease (CVD) or high cardiovascular risks.Methods: Literature retrieval was conducted in PubMed, Medline, Embase, the Cochrane Central Register of Controlled Trials and Clinicaltrial.gov website from the inception to December 2022. Randomized controlled trials comparing anti-inflammatory therapies with placebo in patients with established CVD or high cardiovas-cular risks were included. The results of the meta-analysis were computed as the risk ratio (RR) with 95% confidence interval (CI).Results: Compared with placebo, anti-inflammatory therapies were associated with decreased incidence of myocardial infarction (MI) (RR = 0.93, 95% CI, 0.88 to 0.98), which was mainly driven by therapies targeting central IL-6 signaling pathway (RR = 0.83, 95% CI, 0.74 to 0.93). IL-1 inhibitors treatment was associated with reduced risks of heart failure (RR = 0.38, 95% CI, 0.18 to 0.80) while lower incidence of stroke was observed in patients with colchicine treatment (RR = 0.47, 95% CI, 0.28 to 0.77). MI events were less frequent in patients over 65 years of age (RR = 0.90, 95% CI, 0.83 to 0.98) or with follow-up duration over 1 year (RR = 0.90, 95% CI, 0.85 to 0.96) when comparing anti-inflammatory therapies with placebo.Conclusions: Anti-inflammatory therapies, especially those targeting the central IL-6 signaling pathway, may serve as promising treating strategies to ameliorate the risk of MI. IL-1 inhibitor and colchicine were associated with decreased risks of heart failure and stroke, respectively. MI risk reduction by anti-inflammatory therapies seemed to be more prominent in older patients with long follow-up duration.
引用
收藏
页数:11
相关论文
共 86 条
  • [1] Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction
    Abbate, Antonio
    Salloum, Fadi N.
    Vecile, Elena
    Das, Anindita
    Hoke, Nicholas N.
    Straino, Stefania
    Biondi-Zoccai, Giuseppe G. L.
    Houser, Jon-Erik
    Qureshi, Ian Z.
    Ownby, Evan D.
    Gustini, Edoardo
    Biasucci, Luigi M.
    Severino, Anna
    Capogrossi, Maurizio C.
    Vetrovec, George W.
    Crea, Filippo
    Baldi, Alfonso
    Kukreja, Rakesh C.
    Dobrina, Aldo
    [J]. CIRCULATION, 2008, 117 (20) : 2670 - 2683
  • [2] Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
    Abbate, Antonio
    Toldo, Stefano
    Marchetti, Carlo
    Kron, Jordana
    Van Tassell, Benjamin W.
    Dinarello, Charles A.
    [J]. CIRCULATION RESEARCH, 2020, 126 (09) : 1260 - 1280
  • [3] Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction
    Abbate, Antonio
    Trankle, Cory R.
    Buckley, Leo F.
    Lipinski, Michael J.
    Appleton, Darryn
    Kadariya, Dinesh
    Canada, Justin M.
    Carbone, Salvatore
    Roberts, Charlotte S.
    Abouzaki, Nayef
    Melchior, Ryan
    Christopher, Sanah
    Turlington, Jeremy
    Mueller, George
    Garnett, James
    Thomas, Christopher
    Markley, Roshanak
    Wohlford, George F.
    Puckett, Laura
    de Chazal, Horacio Medina
    Chiabrando, Juan G.
    Bressi, Edoardo
    Del Buono, Marco Giuseppe
    Schatz, Aaron
    Vo, Chau
    Dixon, Dave L.
    Biondi-Zoccai, Giuseppe G.
    Kontos, Michael C.
    Van Tassell, Benjamin W.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (05):
  • [4] Reappraising the role of inflammation in heart failure
    Adamo, Luigi
    Rocha-Resende, Cibele
    Prabhu, Sumanth D.
    Mann, Douglas L.
    [J]. NATURE REVIEWS CARDIOLOGY, 2020, 17 (05) : 269 - 285
  • [5] Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice
    Alexander, Matthew R.
    Moehle, Christopher W.
    Johnson, Jason L.
    Yang, Zhengyu
    Lee, Jae K.
    Jackson, Christopher L.
    Owens, Gary K.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (01) : 70 - 79
  • [6] Interleukin-6 promotes a sustained loss of endothelial barrier function via Janus kinase-mediated STAT3 phosphorylation and de novo protein synthesis
    Alsaffar, Hiba
    Martino, Nina
    Garrett, Joshua P.
    Adam, Alejandro P.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2018, 314 (05): : C589 - C602
  • [7] The pathophysiology of cigarette C-V smoking and cardiovascular disease - An update
    Ambrose, JA
    Barua, RS
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (10) : 1731 - 1737
  • [8] Infarct in the Heart: What's MMP-9 Got to Do with It?
    Becirovic-Agic, Mediha
    Chalise, Upendra
    Daseke, Michael J., II
    Konfrst, Shelby
    Salomon, Jeffrey D.
    Mishra, Paras K.
    Lindsey, Merry L.
    [J]. BIOMOLECULES, 2021, 11 (04)
  • [9] INTERLEUKIN-1 (IL-1) INDUCES BIOSYNTHESIS AND CELL-SURFACE EXPRESSION OF PROCOAGULANT ACTIVITY IN HUMAN VASCULAR ENDOTHELIAL-CELLS
    BEVILACQUA, MP
    POBER, JS
    MAJEAU, GR
    COTRAN, RS
    GIMBRONE, MA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (02) : 618 - 623
  • [10] Environmental Determinants of Cardiovascular Disease
    Bhatnagar, Aruni
    [J]. CIRCULATION RESEARCH, 2017, 121 (02) : 162 - 180